Responsible nanotechnology development
暂无分享,去创建一个
[1] Stephen M. Roberts,et al. Characterization of Nanomaterials for Toxicological Evaluation , 2009 .
[2] Igor Linkov,et al. Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop , 2008, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[3] D. Tomalia. Dendrons/dendrimers: quantized, nano-element like building blocks for soft-soft and soft-hard nano-compound synthesis , 2010 .
[4] Maria Dusinska,et al. Testing strategies for the safety of nanoparticles used in medical applications. , 2009, Nanomedicine.
[5] William A. Goddard,et al. Handbook of Nanoscience, Engineering, and Technology , 2002 .
[6] Mihail C. Roco,et al. National Nanotechnology Initiative - Past, Present, Future , 2007 .
[7] Lang Tran,et al. Safe handling of nanotechnology , 2006, Nature.
[8] Ruchika Nijhara,et al. Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[9] Andrew D. Maynard,et al. Don't define nanomaterials , 2011, Nature.
[10] Steffen Foss Hansen,et al. Late lessons from early warnings for nanotechnology. , 2008, Nature nanotechnology.
[11] R. Kannan,et al. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.
[12] N. Rosato,et al. Public optimism towards nanomedicine , 2011, International journal of nanomedicine.
[13] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[14] R. Hurt,et al. Nanotoxicology: the asbestos analogy revisited. , 2008, Nature nanotechnology.
[15] Christy L. Haynes,et al. Functional assessment of metal oxide nanoparticle toxicity in immune cells. , 2010, ACS nano.
[16] K. Mizuno,et al. Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation , 2012, Nanotoxicology.
[17] K. Mizuno,et al. Pulmonary toxicity of well-dispersed single-wall carbon nanotubes after inhalation , 2012, Nanotoxicology.
[18] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[19] W. Liu,et al. Impact of silver nanoparticles on human cells: Effect of particle size , 2010, Nanotoxicology.
[20] Maurizio Chiriva-Internati,et al. Nanotechnology and human health: risks and benefits , 2010, Journal of applied toxicology : JAT.
[21] A. Stirling,et al. Opening Up the Politics of Knowledge and Power in Bioscience , 2012, PLoS biology.
[22] M. Kandlikar,et al. The impact of toxicity testing costs on nanomaterial regulation. , 2009, Environmental science & technology.
[23] Chris Toumey,et al. Democratizing nanotech, then and now. , 2011, Nature nanotechnology.
[24] Steffen Foss Hansen,et al. Categorization framework to aid hazard identification of nanomaterials , 2007 .
[25] Antonio Nunes,et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. , 2011, The American journal of pathology.
[26] Paul A Schulte,et al. Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials. , 2010, Toxicology.
[27] Donald A. Tomalia,et al. In quest of a systematic framework for unifying and defining nanoscience. , 2012, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[28] Saber M Hussain,et al. Surface charge of gold nanoparticles mediates mechanism of toxicity. , 2011, Nanoscale.
[29] Yinfa Ma. In Vitro Models for Nanotoxicity Testing , 2009 .
[30] Serdar Durdagi,et al. In Silico Drug Screening Approach for the Design of Magic Bullets: A Successful Example with Anti-HIV Fullerene Derivatized Amino Acids , 2009, J. Chem. Inf. Model..
[31] The complexity of public engagement. , 2012, Nature nanotechnology.
[32] Robert Langer,et al. On firm ground: IP protection of therapeutic nanoparticles , 2010, Nature Biotechnology.
[33] M. Moore,et al. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? , 2006, Environment international.
[34] David Schneider,et al. Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells , 2011, Nanotoxicology.
[35] Bengt Fadeel,et al. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. , 2010, Advanced drug delivery reviews.
[36] Konrad Hungerbühler,et al. Potential exposure of German consumers to engineered nanoparticles in cosmetics and personal care products , 2011, Nanotoxicology.
[37] Serdar Durdagi,et al. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[38] M. McCall,et al. Environmental, health and safety issues: Nanoparticles in the real world. , 2011, Nature nanotechnology.
[39] Gibson Peter,et al. Considerations on a Definition of Nanomaterial for Regulatory Purposes , 2010 .
[40] Jim Willis,et al. Science policy considerations for responsible nanotechnology decisions. , 2011, Nature nanotechnology.
[41] M. Prato,et al. Fullerene derivatives: an attractive tool for biological applications. , 2003, European journal of medicinal chemistry.
[42] B. Fadeel,et al. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy. , 2011, Biochemical pharmacology.
[43] David Gee,et al. Late Lessons from Early Warnings: Towards realism and precaution with EMF? , 2009, Pathophysiology : the official journal of the International Society for Pathophysiology.
[44] Jerzy Leszczynski,et al. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.
[45] Geoffrey L. Cohen,et al. Cultural cognition of the risks and benefits of nanotechnology. , 2009, Nature nanotechnology.
[46] David B Warheit,et al. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[47] Mihail C Roco,et al. Nanotechnology's future. , 2006, Scientific American.